Collegium Pharmaceutical (COLL) reported second-quarter 2026 product revenues, net of $199.9 million, up 6% from $188.0 million a year earlier. The company posted a GAAP net loss of $15.1 million, or $0.46 per share basic and diluted, compared with GAAP net income of $12.0 million, or $0.38 basic and $0.34 diluted, in the prior-year quarter.
Collegium said it completed the acquisition of AZSTARYS in May, adding to its ADHD portfolio. The company updated full-year 2026 guidance, lowering product revenues, net to $825 million to $855 million and adjusted EBITDA to $445 million to $470 million, while raising AZSTARYS revenue, net guidance to $65 million to $75 million.
- JORNAY PM net revenue was $46.1 million in the quarter, up 41% year over year.
- AZSTARYS net revenue was $12.9 million from May 12, 2026, to June 30, 2026.
- Pain portfolio net revenues were $140.9 million, down 9% year over year.
- Adjusted EBITDA was $113.8 million, up 8% from $105.1 million a year earlier.
- Collegium generated $71.3 million in cash from operations and ended the quarter with $129.5 million in cash, cash equivalents and marketable securities.
$COLL Insider Trading Activity
$COLL insiders have traded $COLL stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $COLL stock by insiders over the last 6 months:
- DAVID DIETER (EVP & General Counsel) has made 0 purchases and 2 sales selling 20,200 shares for an estimated $716,208.
- GAREN G BOHLIN sold 8,700 shares for an estimated $323,491
- NANCY LURKER sold 4,500 shares for an estimated $161,860
- JOHN GORDON FREUND has made 0 purchases and 2 sales selling 4,147 shares for an estimated $143,227.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$COLL Hedge Fund Activity
We have seen 131 institutional investors add shares of $COLL stock to their portfolio, and 123 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- EVENTIDE ASSET MANAGEMENT, LLC removed 451,957 shares (-24.1%) from their portfolio in Q1 2026, for an estimated $14,946,217
- EMERALD ADVISERS, LLC removed 401,703 shares (-99.7%) from their portfolio in Q2 2026, for an estimated $14,541,648
- QUBE RESEARCH & TECHNOLOGIES LTD added 353,693 shares (+131.9%) to their portfolio in Q1 2026, for an estimated $11,696,627
- PRINCIPAL FINANCIAL GROUP INC added 337,332 shares (+26.0%) to their portfolio in Q2 2026, for an estimated $12,211,418
- EMERALD MUTUAL FUND ADVISERS TRUST removed 306,074 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $11,079,878
- MILLENNIUM MANAGEMENT LLC added 290,543 shares (+413.4%) to their portfolio in Q1 2026, for an estimated $9,608,257
- MARSHALL WACE, LLP added 256,452 shares (+52.1%) to their portfolio in Q1 2026, for an estimated $8,480,867
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
